Latest News
SLT laser
SLT laser is a form of "cold laser" that does not burn the trabecular meshwork - rather it stimulates it to enhance drainage of fluid out of the eye. The results are modestly impressive - 5 year results indicate a 20-30% drop in eye pressure. It is a treatment that can be repeated, and surgery to control pressure can be delayed or postponed indefinitely as a result.Latest items
Popular
Glaucoma news
Memantine is a new drug for glaucoma, that has undergone extensive trials to establish its effectiveness. Disappointingly, it has not demonstrated the benefits expected, and plans to release this medication in the UK are therefore on hold.News
| Memantine and neuroprotection in mice |
|
|
|
| Written by Administrator | |
| Monday, 12 November 2007 | |
| The new drug memantine with potential use in glaucoma, has failed to demonstrate a significant change in the primary outcome measure with treatment (confirmed visual field loss), however an animal model has demonstrated an effect in mice: researchers in Japan have recently noted that glaucoma prone mice deficient in small molecule transporters (GLAST & EAAC1) are significantly protected in terms of ganglion cell loss in the laboratory (3% versus 20% loss). Harada et al The potential role of glutamate transporters... J Clin Invest 2007 117:1763-1770. |
| < Prev | Next > |
|---|




